Rhumbline Advisers Qiagen N.V. Transaction History

Rhumbline Advisers

  • $109 Billion
  • Q3 2024

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 08, 2024
BUY
$35.55 - $43.57 $98,757 - $121,037
2,778 Added 1.1%
255,801 $11.1 Million
Q3 2023

Nov 09, 2023
SELL
$39.13 - $47.24 $163,446 - $197,321
-4,177 Reduced 1.62%
253,023 $10.2 Million
Q2 2023

Aug 08, 2023
BUY
$43.93 - $46.76 $1.16 Million - $1.24 Million
26,466 Added 11.47%
257,200 $11.6 Million
Q1 2023

May 11, 2023
SELL
$45.29 - $50.76 $328,352 - $368,010
-7,250 Reduced 3.05%
230,734 $10.6 Million
Q4 2022

Feb 14, 2023
BUY
$41.91 - $50.48 $549,649 - $662,045
13,115 Added 5.83%
237,984 $11.9 Million
Q3 2022

Nov 10, 2022
BUY
$40.9 - $50.42 $658,162 - $811,358
16,092 Added 7.71%
224,869 $9.28 Million
Q2 2022

Aug 11, 2022
BUY
$42.98 - $49.77 $1.46 Million - $1.69 Million
33,972 Added 19.43%
208,777 $9.85 Million
Q1 2022

May 12, 2022
SELL
$42.23 - $54.3 $849,709 - $1.09 Million
-20,121 Reduced 10.32%
174,805 $8.57 Million
Q4 2021

Feb 10, 2022
BUY
$50.62 - $56.47 $239,635 - $267,328
4,734 Added 2.49%
194,926 $10.8 Million
Q3 2021

Nov 12, 2021
SELL
$46.55 - $56.83 $807,456 - $985,773
-17,346 Reduced 8.36%
190,192 $9.83 Million
Q2 2021

Aug 05, 2021
SELL
$46.28 - $52.75 $455,626 - $519,323
-9,845 Reduced 4.53%
207,538 $10 Million
Q1 2021

May 06, 2021
SELL
$46.25 - $56.02 $504,818 - $611,458
-10,915 Reduced 4.78%
217,383 $10.6 Million
Q4 2020

Feb 10, 2021
BUY
$46.09 - $54.74 $409,878 - $486,802
8,893 Added 4.05%
228,298 $12.1 Million
Q3 2020

Nov 12, 2020
SELL
$42.51 - $52.42 $224,622 - $276,987
-5,284 Reduced 2.35%
219,405 $11.5 Million
Q2 2020

Aug 13, 2020
BUY
$39.49 - $44.36 $176,599 - $198,377
4,472 Added 2.03%
224,689 $9.62 Million
Q1 2020

May 06, 2020
BUY
$33.17 - $41.6 $1.9 Million - $2.38 Million
57,209 Added 35.1%
220,217 $9.16 Million
Q4 2019

Feb 05, 2020
BUY
$25.41 - $43.1 $20,709 - $35,126
815 Added 0.5%
163,008 $5.51 Million
Q3 2019

Oct 23, 2019
SELL
$32.73 - $40.81 $241,645 - $301,300
-7,383 Reduced 4.35%
162,193 $5.35 Million
Q2 2019

Aug 14, 2019
BUY
$35.73 - $41.39 $346,723 - $401,648
9,704 Added 6.07%
169,576 $6.88 Million
Q1 2019

May 01, 2019
SELL
$33.78 - $40.68 $1.03 Million - $1.24 Million
-30,592 Reduced 16.06%
159,872 $6.5 Million
Q4 2018

Jan 31, 2019
BUY
$32.65 - $37.95 $181,860 - $211,381
5,570 Added 3.01%
190,464 $6.56 Million
Q3 2018

Nov 07, 2018
SELL
$35.99 - $39.39 $148,062 - $162,050
-4,114 Reduced 2.18%
184,894 $7 Million
Q2 2018

Aug 06, 2018
SELL
$31.23 - $37.47 $504,395 - $605,177
-16,151 Reduced 7.87%
189,008 $6.84 Million
Q1 2018

May 02, 2018
SELL
$31.01 - $34.72 $105,558 - $118,186
-3,404 Reduced 1.63%
205,159 $6.63 Million
Q4 2017

Feb 09, 2018
SELL
$30.68 - $35.37 $70,195 - $80,926
-2,288 Reduced 1.09%
208,563 $6.45 Million
Q3 2017

Nov 06, 2017
BUY
$31.02 - $32.94 $6.54 Million - $6.95 Million
210,851
210,851 $6.64 Million

Others Institutions Holding QGEN

# of Institutions
21
Shares Held
6.37M
Call Options Held
0
Put Options Held
0
View Full List

About QIAGEN N.V.

QGEN Quotes by TradingView
  • Ticker QGEN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 227,694,000
  • Market Cap $10.4B
  • Description
  • QIAGEN N.V. offers sample to insight solutions that transform biological materials into molecular insights worldwide. The company provides primary sample technology consumables, such as nucleic stabilization and purification kits for primary sample materials, manual and automated processing for genotyping, gene expression, and viral and bacteria...
More about QGEN
Track This Portfolio

Track Rhumbline Advisers Portfolio

Follow Rhumbline Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email